New Products: MLL's AML/MDS Panel; Adaptive Biotechnologies' ClonoSeq
December 12, 2012
New Products: MLL's AML/MDS Panel; Adaptive Biotechnologies' ClonoSeq
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Adaptive Bio, Bristol-Myers Squibb Collaborate on Cancer Biomarkers
May 9, 2013 / GenomeWeb Daily News - Emory, CHOP, Harvard to Develop Medical Exome for Complete Coverage of 5K Disease-associated Genes
May 1, 2013 / Clinical Sequencing News - Myriad Partners with RainDance for Front End of NGS-based Hereditary Cancer Panel Test
April 17, 2013 / Clinical Sequencing News - People in the News: Robert Hershberg
March 6, 2013 / Clinical Sequencing News - Adaptive Biotech Targets Year End for CLIA Certification, Assay to Detect Residual Leukemia
May 23, 2012 / Clinical Sequencing News